Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Right-wing media pushed a deworming drug to treat Covid-19 that the FDA says is unsafe for humans
New York (CNN Business) - Public health officials are aggressively dispelling claims by right-wing media personalities who have been promoting an anti-parasitic drug used for livestock as a po...
Pfizer to Acquire Trillium Therapeutics Inc.
NEW YORK & CAMBRIDGE, Mass.
Evrenzo™ approved for CKD-related anaemia treatment in EU
The European Commission (EC) has approved Astellas’ Evrenzo™ for adult patients with symptomatic anaemia of chronic kidney disease (CKD).
BMS obtains FDA approval for Opdivo as bladder cancer treatment
The US Food and Drug Administration has approved Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) as an adjuvant therapy for urothelial carcinoma (UC) patients at increased ri...
FDA Approves First COVID-19 Vaccine
Today, the U.
Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome
Copenhagen, DK and Boston, MA, U.
Sutro (STRO) Ovarian Cancer Drug Gets FDA's Fast Track Tag
Sutro Biopharma STRO announced that the FDA has granted Fast Track designation to its drug STRO-002, a folate receptor (“FR”) alpha-targeting antibody-drug conjugate (“ADC”), t...
Pimavanserin Use Linked With Greater Risk of Hospitalization, Mortality in Patients With Parkinson Disease
Pimavanserin (Nuplazid) initiation among patients with Parkinson disease was associated with greater risk of 30-day hospitalization and mortality up to one year compared with non-users.
US approval for Boehringer Ingelheim, Lilly's heart failure drug Jardiance
Jardiance (empagliflozin) has been approved by the US Food and Drug Administration (FDA) to reduce the risk of cardiovascular death plus hospitalisation for adults with heart failure w...
Lilly Bio-Medicines splits into neuroscience, immunology units
Eli Lilly has divided Lilly Bio-Medicines into neuroscience and immunology business units.
Otsuka reports topline outcomes on a phase II trial that evaluated brexpiprazole for the treatment of borderline personality disorder
Otsuka Pharmaceutical Co.
South Korea aims to make vaccine industry more competitive with emphasis on COVID-19, says GlobalData
South Korea has recently unveiled a US$2bn plan to emerge as a global COVID-19 vaccine production hub and become one of the top five manufacturing bases by 2025.
227
228
229
230
231
232
233
234
235
